Form 8-K - Current report:
SEC Accession No. 0001213900-25-011315
Filing Date
2025-02-07
Accepted
2025-02-07 16:09:37
Documents
18
Period of Report
2025-02-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0230166-8k_cadrenal.htm   iXBRL 8-K 36027
2 EMPLOYMENT AGREEMENT BETWEEN CADRENAL THERAPEUTICS, INC. AND JAMES J. FERGUSON I ea023016601ex10-1_cadrenal.htm EX-10.1 100889
3 SEVERANCE AND RELEASE LETTER AGREEMENT, DATED FEBRUARY 7, 2025, BETWEEN CADRENAL ea023016601ex10-2_cadrenal.htm EX-10.2 55927
4 PRESS RELEASE ISSUED BY CADRENAL THERAPEUTICS, INC. ON FEBRUARY 6, 2025 ea023016601ex99-1_cadrenal.htm EX-99.1 14666
5 GRAPHIC ex99-1_001.jpg GRAPHIC 2221
6 GRAPHIC ex99-1_002.jpg GRAPHIC 2206
  Complete submission text file 0001213900-25-011315.txt   439301

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cvkd-20250204.xsd EX-101.SCH 3015
8 XBRL LABEL FILE cvkd-20250204_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE cvkd-20250204_pre.xml EX-101.PRE 22359
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0230166-8k_cadrenal_htm.xml XML 3799
Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41596 | Film No.: 25601783
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)